Prostate Cancer News

The single, easiest way to keep track of all the stocks that matter... Your own personalized stock watchlist! It's a 100% FREE Motley Fool service... If the JPMorgan Healthcare Conference in January is the mecca of all health-care events during the year, then the American Society of Clinical Oncology's annual meeting in Chicago beginning late next ... (more)

Health screening tests greatly impact the public's health because they involve testing of asymptomatic populations for specific diseases or health conditions for which specific interventions may alter disease progression before appearance of clinical signs and symptoms.

Main Category: Prostate / Prostate Cancer Also Included In: Breast Cancer ; Lung Cancer Article Date: 24 May 2013 - 0:00 PDT By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ... (more)

While many patients may think "doctor knows best" when choosing between different medical procedures, a new study from the California HealthCare Foundation found that some of these decisions may be driven more by local physician preferences rather than clinical evidence.

Every year, thousand and thousands of men are diagnosed with prostate cancer. Many are treated and soon cancer free, but experts all say, the key is catching the cancer early.

Diagnosing prostate cancer could become much easier, thanks to original technology from Rockefeller University that allows scientists to "paint" individual tumors under a microscope.

Astellas Pharma Inc. and Medivation, Inc. today announced that Astellas has submitted an application for marketing approval of enzalutamide to the Ministry of Health, Labour and Welfare in Japan for the treatment of prostate cancer .

Why does a food or supplement seem to help with a disease? Understanding the "why" triggers a lot of progress in a battle against that disease, so that future treatments can be made to mimic that same action.

Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to UC Irvine research published in the /i>Journal of the American Chemical Society.

Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to UC Irvine research published in the /i>Journal of the American Chemical Society.

The need to add tissue preserving therapies to the prostate cancer treatment continuum was highlighted prominently at the 108th Annual Meeting of the American Urological Association , in San Diego.

February 12, 2013 - Sanofi US today announced that ten company-supported abstracts covering ongoing prostate cancer research will be presented on February 14 and 15 during the 2013 Genitourinary Cancers Symposium in Orlando, FL.

Intuitive Surgical Inc. prevailed at a trial against claims it was negligent in its training of a doctor who performed a robot-assisted surgery on a patient who later died.

Mayo Clinic researchers have used next generation genomic analysis to determine that some of the more aggressive prostate cancer tumors have similar genetic origins, which may help in predicting cancer progression.

ConsumerAffairs' culture and lifestyle reporter, Daryl Nelson has written for Readers Digest, Townsquare Media, AllHipHop.com and a number of other online and print publications.

To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document.

A TUTOR led dozens of people on a course all about cancer - and then realised he had the symptoms himself.

Some prostate cancer patients unnecessarily undergo surgery or harsh treatments because science fails to identify the differences between slow-growing and aggressive forms of the disease.

Northwest Biotherapeutics , a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, announced today that it will use its exhibit at this year's American Society Of Clinical Oncology meeting in Chicago to highlight its leadership role in immune therapy.

The analysis of exonic DNA from prostate cancers has identified recurrently mutated genes, but the spectrum of genome-wide alterations has not been profiled extensively in this disease.